Clinical Trials Directory

Trials / Completed

CompletedNCT02793453

Antimicrobial Peptides in Periodontitis

Antimicrobial Peptides in Periodontitis : a Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
29 (actual)
Sponsor
CHU de Reims · Academic / Other
Sex
All
Age
35 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Periodontal diseases are complex chronic pathologies presenting a high prevalence worldwide. Etiopathological process involved in initiation and progression of these multifactorial diseases are not well understood, explaining the huge clinical forms variability and the complexity of the currently used classification of periodontal diseases. Recently, the implication of antimicrobial peptides (AMPs) have been suggested as potential track of explanation for periodontal diseases pathogeny. The here presented study explore the level of expression of genes coding those peptides by studying periodontal smears obtained from healthy and periodontitis patients.

Detailed description

This study explore the level of expression of genes coding those peptides by studying Messenger RNA (mRNA) purified from periodontal smears obtained from healthy and periodontitis patients by "Masterpure©" protocol.After reverse transcription (RT-PCR), in-silico design of primers and specificity and efficiency calculation, Complementary DNA (cDNA) are quantified by a semi-quantitative method (delta-delta CT) vs a Housekeeping gene. Wilcoxon-Mann \& Whitney tests and Chi² tests are performed to check the significativity of the results between groups.

Conditions

Interventions

TypeNameDescription
OTHERperiodontal smears

Timeline

Start date
2016-01-19
Primary completion
2016-03-23
Completion
2016-04-01
First posted
2016-06-08
Last updated
2026-01-21

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02793453. Inclusion in this directory is not an endorsement.